SCHEMBL23329432

SCHEMBL23329432

CC12C3CCC1CC2(NC(=O)c1cc(-c2cncs2)cc2[nH]ccc12)C3

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 19/20 0.62
▸ GHSR Q92847 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24963464 0.81 CD38 (0.60) CD38GHSR
SCHEMBL23304853 0.81 CD38 (0.64) CD38
SCHEMBL23304684 0.80 CD38 (0.74) CD38
SCHEMBL23329148 0.79 CD38 (0.60) CD38GHSR
SCHEMBL23329185 0.78 CD38 (0.86) CD38
SCHEMBL23329326 0.78 CD38 (0.86) CD38
SCHEMBL23305725 0.77 CD38 (0.61) CD38
SCHEMBL23304751 0.77 CD38 (0.85) CD38
SCHEMBL23329112 0.77 CD38 (1.00) CD38
SCHEMBL23329426 0.77 CD38 (0.71) CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 — — WO disclosed
Send feedback